-A +A
Text Size
Home » News and Research » Follicular Thyroid Cancer

Follicular Thyroid Cancer News and Research

Too little blood-borne adiponectin may boost risk of thyroid cancer
10/03/2011 - Research conducted by a team of Greek and American endocrinologists has revealed that too little of the metabolic protein adiponectin in the blood may increase the likelihood of thyroid cancer, while higher levels may entail a lower-than-average risk of the disease.
PTEN hamartoma tumor syndrome boosts risk of thyroid cancer, even in childhood
09/29/2011 - Among people with phosphatase and tensin homolog (PTEN) hamartoma tumor syndrome (PHTS), the lifetime risk of developing thyroid cancer is much higher - even in childhood, according to a recent set of case studies.
Article reviews rare cardiac metastases of thyroid cancer
08/17/2011 - Even among the most virulent types of metastatic thyroid cancer, the carcinoma is very unlikely to migrate to the heart, which is why a team of Australian researchers recently compiled a list of all cardiac metastases of thyroid tumors (CMTTs) recorded in the last 130 years.
Age, tumor size affect metastasis, prognosis for patients with follicular thyroid cancer
07/18/2011 - Though it is not the most virulent form of thyroid carcinoma, follicular thyroid cancer (FTC) is more likely than the papillary variety to spread to distant sites in the body, which is one reason why Japanese researchers recently analyzed the factors affecting the metastasis of FTC.
Protein tests predict recurrence of papillary or follicular thyroid cancer
06/03/2011 - Some experts are unsure of the ability of protein-based tests to predict the return of thyroid carcinomas, which is why a team of scientists recently monitored the recurrence of papillary thyroid cancer (PTC) or follicular thyroid cancer (FTC) among patients given serum thyroglobulin (Tg) assays.
Scientists explore how thyroid cancer metastasizes, often staying dormant for years
05/23/2011 - Distant metastases of thyroid cancer can dramatically reduce a patient's likelihood of survival, which is one reason why a scientist at the Ohio State University College of Medicine recently reviewed the current clinical understanding of how thyroid carcinoma cells migrate.
Macrocephaly points to likelihood of PTEN mutation in follicular thyroid cancer patients
05/20/2011 - Among people with a mutation of a particular gene called PTEN, the rate of differentiated thyroid cancer (DTC) is between 3 and 10 percent, but until recently, researchers had not tabulated how many patients with follicular thyroid cancer (FTC) typically display the mutation.
Study establishes epidemiology of thyroid cancer by type, demographic group
04/19/2011 - Researchers from the National Cancer Institute (NCI) and several U.S. universities recently analyzed state-based thyroid cancer data in order to determine the incidence of each variety of the disease among American demographic groups.
Researchers explore atypical treatments for medullary thyroid cancer
03/04/2011 - Given that the survival rate for medullary thyroid cancer is not as optimal as those of more common forms of the disease, researchers in Germany have been exploring alternative treatments for instances in which medullary carcinomas do not respond well to radioactive iodine treatment.
Experts recommend 'individualized approach' to treating thyroid cancer in kids
01/27/2011 - A pair of pediatric endocrinologists have recently recommended a more conservative, or "individualized," use of certain therapies to treat thyroid cancer in children and teens.
Study: Thyroid cancer patients with lymphocytic infiltration have less recurrences
09/29/2010 - According to the results of a study reported at the 14th International Thyroid Congress, patients with thyroid cancer who show lymphocytic infiltration - a benign cluster of lymph cells - are more likely to have a favorable outcome.
Certain thyroid cancers have higher incidence of nodal metastases
09/01/2010 - A recent study published in Archives of Otolaryngology - Head and Neck Surgery suggests that malignant central nodal metastases - cancer that spreads to lymph nodes - are more likely to occur in patients with papillary thyroid carcinoma than those with follicular variant papillary thyroid carcinoma.